Patents by Inventor Yvonne Sarah Aratyn

Yvonne Sarah Aratyn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920148
    Abstract: The present application provides materials and methods for treating a patient with one or more conditions associated with ANGPTL3 whether ex vivo or in vivo. In addition, the present application provides materials and methods for editing and/or modulating the expression of ANGPTL3 gene in a cell by genome editing.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: March 5, 2024
    Assignee: CRISPR THERAPEUTICS AG
    Inventors: Ante Sven Lundberg, Samarth Kulkarni, Lawrence Klein, Hari Kumar Padmanabhan, Yvonne Sarah Aratyn
  • Publication number: 20200248168
    Abstract: The present application provides materials and methods for treating a patient with one or more conditions associated with PCSK9 whether ex vivo or in vivo. In addition, the present application provides materials and methods for editing and/or modulating the expression of PCSK9 gene in a cell by genome editing.
    Type: Application
    Filed: February 15, 2018
    Publication date: August 6, 2020
    Inventors: Ante Sven LUNDBERG, Samarth KULKARNI, Lawrence KLEIN, Yvonne Sarah ARATYN, Roman Lvovitch BOGORAD, Hari Kumar PADMANABHAN
  • Publication number: 20200157565
    Abstract: The present application provides materials and methods for treating a patient with one or more conditions associated with ANGPTL3 whether ex vivo or in vivo. In addition, the present application provides materials and methods for editing and/or modulating the expression of ANGPTL3 gene in a cell by genome editing.
    Type: Application
    Filed: February 21, 2018
    Publication date: May 21, 2020
    Inventors: Ante Sven Lundberg, Samarth Kulkarni, Lawrence Klein, Hari Kumar Padmanabhan, Yvonne Sarah Aratyn